Schedule 13G ownership disclosure
MEDIWOUND LTD
Security class unavailable · CUSIP: M68830104
Event date: 2022-11-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,717,552
- Percent of class
- 12.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-22-004233
- Form type
- SC 13G
- Filer
- Israel Biotech Fund II, L.P.
- CIK
- CIK 1782947
- Filed
- Dec 05, 2022
- Reporting period
- Nov 28, 2022
- Description
- Schedule 13G beneficial ownership